Hydrogels for ocular drug delivery and tissue engineering

BioImpacts

Volumn 5, Issue 4, 2015, Pages 159-164

  Fathi, Marzieh ^a   Barar, Jaleh ^a   Aghanejad, Ayoub ^a   Omidi, Yadollah ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cell therapy; Drug delivery; Eye; Hydrogels; Ocular diseases; Tissue engineering

Indexed keywords

POLYMER;

ARTICLE; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; ENVIRONMENTAL FACTOR; EYE DISEASE; HUMAN; HYDROGEL; INTRAOCULAR DRUG ADMINISTRATION; LIGHT EXPOSURE; OUTCOME ASSESSMENT; PH; RISK FACTOR; TEMPERATURE SENSITIVITY; TISSUE ENGINEERING; TRANSPORT KINETICS;

EID: 84958155033     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.15171/bi.2015.31     Document Type: Article

References (45)

1. Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 2008; 60: 1638-49.
2. Ahmed EM. Hydrogel: preparation, characterization, and applications. J Adv Res 2015; 6: 105-21.
3. Hennink W, Van Nostrum CF. Novel crosslinking methods to design hydrogels. Adv Drug Deliv Rev 2012; 64: 223-36.
4. Hoare TR, Kohane DS. Hydrogels in drug delivery: Progress and challenges. Polymer 2008; 49: 1993-2007. doi: 10.1016/j.polymer.2008.01.027
5. Yeo Y, Bellas E, Highley CB, Langer R, Kohane DS. Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated-injury model. Biomaterials 2007; 28: 3704-13. doi: 10.1016/j.biomaterials.2007.04.033
6. Yeo Y, Adil M, Bellas E, Astashkina A, Chaudhary N, Kohane DS. Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide. J Control Release 2007; 120: 178-85. doi: 10.1016/j.jconrel.2007.04.016
7. Joglekar M, Trewyn BG. Polymer-based stimuli-responsive nanosystems for biomedical applications. Biotechnol J 2013; 8: 931-45.
8. Deligkaris K, Tadele TS, Olthuis W, van den Berg A. Hydrogel-based devices for biomedical applications. Sensors and Actuators B: Chemical 2010; 147: 765-74.
9. Radhakrishnan J, Krishnan UM, Sethuraman S. Hydrogel based injectable scaffolds for cardiac tissue regeneration. Biotechnol Adv 2014; 32: 449-61.
10. Chan A, Orme RP, Fricker RA, Roach P. Remote and local control of stimuli responsive materials for therapeutic applications. Adv Drug Deliv Rev 2013; 65: 497-514.
11. Alvarez-Lorenzo C, Concheiro A. Intelligent drug delivery systems: polymeric micelles and hydrogels. Mini Reviews in Medicinal Chemistry 2008; 8: 1065-74.
12. Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002; 54: 37-51.
13. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev 2012; 64: 49-60.
14. Casolaro M, Casolaro I, Lamponi S. Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery. Eur J Pharm Biopharm 2012; 80: 553-61.
15. Fathi M, Entezami AA, Arami S, Rashidi MR. Preparation of N-Isopropylacrylamide/Itaconic Acid Magnetic Nanohydrogels by Modified Starch as a Crosslinker for Anticancer Drug Carriers. International Journal of Polymeric Materials and Polymeric Biomaterials 2015; 64: 541-9.
16. Kharkar PM, Kiick KL, Kloxin AM. Design of Thiol- and Light-sensitive Degradable Hydrogels using Michael-type Addition Reactions. Polym Chem 2015; 6: 5565-74. doi: 10.1039/C5PY00750J
17. Fathi M, Entezami AA, Pashaei-Asl R. Swelling/deswelling, thermal, and rheological behavior of PVA-g-NIPAAm nanohydrogels prepared by a facile free-radical polymerization method. Journal of Polymer Research 2013; 20: 1-11.
18. Saleh-Ghadimi L, Fathi M, Entezami AA. Heteroarm star-shaped poly (N-isopropylacryamide-co-itaconic acid) copolymer prepared by glucose core as ATRP initiator. International Journal of Polymeric Materials and Polymeric Biomaterials 2014; 63: 246-55.
19. Park H, Temenoff JS, Tabata Y, Caplan AI, Mikos AG. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 2007; 28: 3217-27.
20. Bhattarai N, Ramay HR, Gunn J, Matsen FA, Zhang M. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J Control Release 2005; 103: 609-24.
21. Willoughby CE, Ponzin D, Ferrari S, Lobo A, Landau K, Omidi Y. Anatomy and physiology of the human eye: effects of mucopolysaccharidoses disease on structure and function-a review. Clin Experiment Ophthalmol 2010; 38: 2-11.
22. Barar J, Asadi M, Mortazavi-Tabatabaei SA, Omidi Y. Ocular drug delivery: impact of in vitro cell culture models. J Ophth Vis Res 2009; 4: 238-52.
23. Adibkia K, Omidi Y, Siahi MR, Javadzadeh AR, Barzegar-Jalali M, Barar J, et al. Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits. J Ocul Pharmacol Ther 2007; 23: 421-32. doi:10.1089/jop.2007.0039
24. Adibkia K, Siahi Shadbad MR, Nokhodchi A, Javadzedeh A, Barzegar-Jalali M, Barar J, et al. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis. J Drug Target 2007; 15: 407-16. doi: 10.1080/10611860701453125
25. Omidi Y, Barar J, Hamzeiy H. Nanomedicines Impacts in Ocular Delivery and Targeting. Nanotechnology in Health Care 2012; 43.
26. Barar J, Omidi Y. Nanoparticles for Ocular Drug Delivery. Nanomedicine in Drug Delivery 2013; 287.
27. Yasuda H. Biocompatibility of Nanofilm-Encapsulated Silicone and Silicone-Hydrogel Contact Lenses. Macromol Biosci 2006; 6: 121-38.
28. Abrego G, Alvarado H, Souto EB, Guevara B, Bellowa LH, Parra A, et al. Biopharmaceutical profile of pranoprofen-loaded PLGA nanoparticles containing hydrogels for ocular administration. Eur J Pharm Biopharm 2015; 95(Pt B): 261-70. doi: 10.1016/j.ejpb.2015.01.026.
29. Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm 2002; 28: 353-69.
30. Wright B, Mi S, Connon CJ. Towards the use of hydrogels in the treatment of limbal stem cell deficiency. Drug Discov Today 2013; 18: 79-86. doi: 10.1016/j.drudis.2012.07.012
31. Feng Y, Borrelli M, Reichl S, Schrader S, Geerling G. Review of alternative carrier materials for ocular surface reconstruction. Curr Eye Res 2014; 39: 541-52. doi: 10.3109/02713683.2013.853803
32. Perez EP, Merrill EW, Miller D, Cima LG. Corneal epithelial wound healing on bilayer composite hydrogels. Tissue Eng 1995; 1: 263-77. doi: 10.1089/ten.1995.1.263
33. Ahearne M, Yang Y, El Haj AJ, Then KY, Liu KK. Characterizing the viscoelastic properties of thin hydrogel-based constructs for tissue engineering applications. J R Soc Interface 2005; 2: 455-63. doi: 10.1098/rsif.2005.0065
34. Wright B, Cave RA, Cook JP, Khutoryanskiy VV, Mi S, Chen B, et al. Enhanced viability of corneal epithelial cells for efficient transport/storage using a structurally modified calcium alginate hydrogel. Regen Med 2012; 7: 295-307. doi: 10.2217/rme.12.7
35. Mimura T, Amano S, Yokoo S, Uchida S, Yamagami S, Usui T, et al. Tissue engineering of corneal stroma with rabbit fibroblast precursors and gelatin hydrogels. Mol Vis 2008; 14: 1819-28.
36. Rafat M, Li F, Fagerholm P, Lagali NS, Watsky MA, Munger R, et al. PEG-stabilized carbodiimide crosslinked collagen-chitosan hydrogels for corneal tissue engineering. Biomaterials 2008; 29: 3960-72. doi: 10.1016/j.biomaterials.2008.06.017
37. Bakhshandeh H, Soleimani M, Hosseini SS, Hashemi H, Shabani I, Shafiee A, et al. Poly (epsilon-caprolactone) nanofibrous ring surrounding a polyvinyl alcohol hydrogel for the development of a biocompatible two-part artificial cornea. Int J Nanomedicine 2011; 6: 1509-15. doi:10.2147/IJN.S19011
38. Grolik M, Szczubialka K, Wowra B, Dobrowolski D, Orzechowska-Wylegala B, Wylegala E, et al. Hydrogel membranes based on genipin-cross-linked chitosan blends for corneal epithelium tissue engineering. J Mater Sci Mater Med 2012; 23: 1991-2000. doi: 10.1007/s10856-012-4666-7
39. Ozcelik B, Brown KD, Blencowe A, Daniell M, Stevens GW, Qiao GG. Ultrathin chitosan-poly(ethylene glycol) hydrogel films for corneal tissue engineering. Acta Biomater 2013; 9: 6594-605. doi: 10.1016/j.actbio.2013.01.020
40. Chae JJ, Mulreany DG, Guo Q, Lu Q, Choi JS, Strehin I, et al. Application of a collagen-based membrane and chondroitin sulfate-based hydrogel adhesive for the potential repair of severe ocular surface injuries. Mil Med 2014; 179: 686-94. doi: 10.7205/MILMED-D-13-00360
41. Xiao X, Pan S, Liu X, Zhu X, Connon CJ, Wu J, et al. In vivo study of the biocompatibility of a novel compressed collagen hydrogel scaffold for artificial corneas. J Biomed Mater Res A 2014; 102: 1782-7. doi: 10.1002/jbm.a.34848
42. Wittmann K, Dietl S, Ludwig N, Berberich O, Hoefner C, Storck K, et al. Engineering vascularized adipose tissue using the stromal-vascular fraction and fibrin hydrogels. Tissue Eng Part A 2015; 21: 1343-53. doi: 10.1089/ten.TEA.2014.0299
43. Ahmed TA, Dare EV, Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 2008; 14: 199-215. doi: 10.1089/ten.teb.2007.0435
44. Patchan MW, Chae JJ, Lee JD, Calderon-Colon X, Maranchi JP, McCally RL, et al. Evaluation of the biocompatibility of regenerated cellulose hydrogels with high strength and transparency for ocular applications. J Biomater Appl 2015. doi: 10.1177/0885328215616273
45. Stapleton F, Stretton S, Papas E, Skotnitsky C, Sweeney DF. Silicone hydrogel contact lenses and the ocular surface. Ocul Surf 2006; 4: 24-43.